Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Anemia 4Neoplasms 2Uterine Cervical Neoplasms 1Thalassemia 1Myelodysplastic Syndromes 1Leukemia 1Hematologic Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

fludarabine phosphate 4fludarabine 3Cyclophosphamide 3Busulfan 3Antilymphocyte Serum 3Whole-Body Irradiation 2Thiotepa 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Bone Marrow Transplantation 2Alemtuzumab 2treosulfan 1thymoglobulin 1X-Rays 1Specimen Handling 1Passive Cutaneous Anaphylaxis 1Mycophenolic Acid 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Methadone 1Hydromorphone 1Genetic Counseling 1Erythrocyte Transfusion 1Emapalumab 1Cyclosporins 1Clofarabine 1Clinical Trials, Phase I as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Blood Transfusion × Classical hematology × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡